Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
13 hedge funds and large institutions have $174K invested in Histogen Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
30% more funds holding
Funds holding: 10 → 13 (+3)
24% less capital invested
Capital invested by funds: $229K → $174K (-$55K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$61.4K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$24.6K |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$14.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$26K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$24K |
| 3 |
JP Morgan Chase
New York
|
-$13K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.76K |
HSTO Hedge Fund Activity: Q3 2022 in Review
13 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q3 2022, worth a combined $174K — down 24% from $229K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new HSTO positions and 3 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $61.4K. The largest seller was HRT Financial, exiting entirely with an estimated $26K sold.
- 13 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q3 2022, up from 10 in Q2 2022.
- Funds reported $174K of Histogen Inc. Common Stock stock for Q3 2022, down 24% quarter-over-quarter.
- 6 funds opened new Histogen Inc. Common Stock positions in Q3 2022 and 3 closed out, a net change of +3 holders.
- The largest Histogen Inc. Common Stock buyer in Q3 2022 was Virtu Financial, an estimated $61.4K added.
- The largest Histogen Inc. Common Stock seller in Q3 2022 was HRT Financial, an estimated $26K sold.
Based on aggregated 13F filings for Q3 2022.